Tag Archives: Viking

Finding life beyond the Earth would be a major scientific discovery with significant implications for all areas of science and human thought. Yet, only one direct search for extraterrestrial life has ever been conducted. The Viking missions landed on the Martian surface using parachutes. This diagram shows each stage the spacecraft went through as they landed. NASA The NASA Viking …

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01. A new oral weight loss drug developed by Viking Therapeutics hit the mark in a mid-stage clinical trial, but the …

Viking Therapeutics Shorts Reap $514 Million as Stock Falls 40%  Bloomberg Viking Therapeutics stock crashes after weight-loss pill trial shows high dropout rate  Yahoo Finance Viking Therapeutics shares fall 40% on disappointing obesity pill trial data  CNBC High drop-out rate clouds weight loss data for Viking’s oral drug  FirstWord Pharma This Weight-Loss Stock Is Down 40%. It Lowers the Risks for Eli Lilly and …

Key Takeaways Viking Therapeutics reported a large number of patients dropped out of a study of its experimental weight-loss pill. Overall, 28% of those taking VK2735 left the Phase 2 trial early compared with 18% among placebo subjects. The research showed the pill reduced the weight of patients who took it for 13 weeks by up to 26.7 pounds. Viking …

Intel, Home Depot, Palo Alto, Viking Therapeutics, Palantir, Medtronic, and More Movers  Barron’s Stocks making the biggest moves premarket: Intel, Palo Alto Networks, Best Buy and more  CNBC 5 Things to Know Before the Stock Market Opens  Investopedia Stocks to Watch Recap: Intel, Medtronic, Home Depot, Rocket Lab  The Wall Street Journal Stock Movers: Home Depot, Intel, Nvidia  Bloomberg Source link

Viking Therapeutics loses a third of its value after oral weight-loss drug trial  MarketWatch Viking Therapeutics shares fall 40% on disappointing obesity pill trial data  CNBC Viking Therapeutics (VKTX) Stock Fell More Than 30%. What Sent It Crashing.  Barron’s Viking’s oral pill reduces up to 12.2% weight but shares slump on higher patient exits  Reuters Viking Therapeutics Rises as Phase 3 Trials and Oral …

Investing.com — Viking Therapeutics (NASDAQ:VKTX) stock plunged as much as 37% Tuesday after revealing results from its Phase 2 VENTURE-Oral Dosing trial for its oral obesity treatment, while Eli Lilly (NYSE:LLY) shares gained 1.5% as analysts pointed to competitive advantages. The trial demonstrated that Viking’s oral tablet formulation of VK2735, a dual GLP-1 and GIP receptor agonist, met its primary …

Study Achieves Primary and Secondary Endpoints, Demonstrating Statistically Significant Reductions in Body Weight with Once-Daily VK2735 Dosing as Compared to Placebo Up to 12.2% (26.6 lbs) Mean Weight Loss Observed After 13 Weeks of VK2735 Treatment Compared with 1.3% (2.9 lbs) for Placebo Exploratory Assessment of Low Dose Maintenance Treatment Demonstrates Positive Proof of Concept VK2735 Shown to be Safe …

Viking Therapeutics (VKTX) stock dove on Tuesday following the release of data from a Phase 2 clinical trial of VK2735. This is the pharmaceutical company’s dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. It is being developed in oral and subcutaneous formulations to treat various metabolic disorders, such as obesity. Elevate Your Investing Strategy: …

As the search for life on Mars continues – with the Mars Sample Return program set to return samples of the planet in the early 2030s – one scientist has suggested that we may have already found life on the Red Planet, almost 50 years ago. And then, in what would not be an all-time great first impression, we destroyed …